Skip to main content

Advertisement

Log in

Therapies to Reduce Blood Pressure Acutely

  • Hypertension and Emergency Medicine (T Rainer, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Clinicians make frequent treatment decisions regarding acute blood pressure reduction for the critically ill. Key to the decision making process is a balance between reducing arterial wall stress and maintaining perfusion to vital organs. In this article, we review the physiological considerations underlying acute blood pressure management, including the concept of cerebral autoregulation and its adaptations to chronic hypertension. We then discuss available pharmacological interventions suited for reducing blood pressure acutely. We also discuss specific blood pressure targets in common critical illnesses and consider future directions in this therapeutic area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • of importance

  1. Inscho EW, Lewis K. Dahl Memorial Lecture. Mysteries of renal autoregulation. Hypertension. 2009;53(2):299–306. doi:10.1161/HYPERTENSIONAHA.108.119982.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ono M, Arnaoutakis GJ, Fine DM, Brady K, Easley RB, Zheng Y, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. 2013;41(2):464–71. doi:10.1097/CCM.0b013e31826ab3a1.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Paulson OB, Waldemar G, Schmidt JF, Strandgaard S. Cerebral circulation under normal and pathologic conditions. Am J Cardiol. 1989;63(6):2C–5C.

    Article  CAS  PubMed  Google Scholar 

  4. Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62(5):810–7. doi:10.1161/HYPERTENSIONAHA.113.01063. This manuscript provides a succinct and current review of the cerebrovascular changes induced by chronic hypertension.

    Article  CAS  PubMed  Google Scholar 

  5. Strandgaard S. Autoregulation of cerebral circulation in hypertension. Acta Neurol Scand Suppl. 1978;66:1–82.

    CAS  PubMed  Google Scholar 

  6. Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review. Journal of human hypertension. 2008;22(9):596–607. doi:10.1038/jhh.2008.25.

    Article  CAS  PubMed  Google Scholar 

  7. Keating GM. Clevidipine: a review of its use for managing blood pressure in perioperative and intensive care settings. Drugs. 2014;74(16):1947–60. doi:10.1007/s40265-014-0313-6.

    Article  CAS  PubMed  Google Scholar 

  8. Qureshi AI, Palesch YY. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15(3):559–76. doi:10.1007/s12028-011-9538-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Graffagnino C, Bergese S, Love J, Schneider D, Lazaridis C, LaPointe M, et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial. Cerebrovascular diseases. 2013;36(3):173–80. doi:10.1159/000351149.

    Article  CAS  PubMed  Google Scholar 

  10. Varelas PN, Abdelhak T, Corry JJ, James E, Rehman MF, Schultz L, et al. Clevidipine for acute hypertension in patients with subarachnoid hemorrhage: a pilot study. The International journal of neuroscience. 2014;124(3):192–8. doi:10.3109/00207454.2013.836703.

    Article  CAS  PubMed  Google Scholar 

  11. Jauch EC, Saver JL, Adams Jr HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947. doi:10.1161/STR.0b013e318284056a.

    Article  PubMed  Google Scholar 

  12. Hottinger DG, Beebe DS, Kozhimannil T, Prielipp RC, Belani KG. Sodium nitroprusside in 2014: a clinical concepts review. J Anaesthesiol Clin Pharmacol. 2014;30(4):462–71. doi:10.4103/0970-9185.142799.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cohn JN, McInnes GT, Shepherd AM. Direct-acting vasodilators. Journal of clinical hypertension. 2011;13(9):690–2. doi:10.1111/j.1751-7176.2011.00507.x.

    Article  CAS  PubMed  Google Scholar 

  14. Kandler MR, Mah GT, Tejani AM, Stabler SN, Salzwedel DM. Hydralazine for essential hypertension. The Cochrane database of systematic reviews. 2011;11:CD004934. doi:10.1002/14651858.CD004934.pub4.

    PubMed  Google Scholar 

  15. Frishman WH, Saunders E. Beta-adrenergic blockers. Journal of clinical hypertension. 2011;13(9):649–53. doi:10.1111/j.1751-7176.2011.00515.x.

    Article  CAS  PubMed  Google Scholar 

  16. Sladen RN, Klamerus KJ, Swafford MW, Prough DS, Mann HJ, Leslie JB, et al. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting. Journal of cardiothoracic anesthesia. 1990;4(2):210–21.

    Article  CAS  PubMed  Google Scholar 

  17. Hirschl MM, Binder M, Bur A, Herkner H, Brunner M, Mullner M, et al. Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises. Arch Intern Med. 1995;155(20):2217–23.

    Article  CAS  PubMed  Google Scholar 

  18. Salgado DR, Silva E, Vincent JL. Control of hypertension in the critically ill: a pathophysiological approach. Ann Intensive Care. 2013;3(1):17. doi:10.1186/2110-5820-3-17.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Elliott WJ. Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis. 2006;48(5):316–25. doi:10.1016/j.pcad.2006.02.004.

    Article  PubMed  Google Scholar 

  20. Tsai TT, Nienaber CA, Eagle KA. Acute aortic syndromes. Circulation. 2005;112(24):3802–13. doi:10.1161/CIRCULATIONAHA.105.534198.

    Article  PubMed  Google Scholar 

  21. Kim KH, Moon IS, Park JS, Koh YB, Ahn H. Nicardipine hydrochloride injectable phase IV open-label clinical trial: study on the anti-hypertensive effect and safety of nicardipine for acute aortic dissection. J Int Med Res. 2002;30(3):337–45.

    Article  CAS  PubMed  Google Scholar 

  22. Viau DM, Sala-Mercado JA, Spranger MD, O’Leary DS, Levy PD. The pathophysiology of hypertensive acute heart failure. Heart. 2015;101(23):1861–7. doi:10.1136/heartjnl-2015-307461.

    PubMed  Google Scholar 

  23. Peacock WF, Chandra A, Char D, Collins S, Der Sahakian G, Ding L, et al. Clevidipine in acute heart failure: results of the A Study of Blood Pressure Control in Acute Heart Failure—a Pilot Study (PRONTO). Am Heart J. 2014;167(4):529–36. doi:10.1016/j.ahj.2013.12.023.

    Article  CAS  PubMed  Google Scholar 

  24. Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, et al. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation. 2010;122(19):1975–96. doi:10.1161/CIR.0b013e3181f9a223.

    Article  PubMed  Google Scholar 

  25. Wakai A, McCabe A, Kidney R, Brooks SC, Seupaul RA, Diercks DB, et al. Nitrates for acute heart failure syndromes. The Cochrane database of systematic reviews. 2013;8:CD005151. doi:10.1002/14651858.CD005151.pub2.

    PubMed  Google Scholar 

  26. Levy P, Compton S, Welch R, Delgado G, Jennett A, Penugonda N, et al. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann Emerg Med. 2007;50(2):144–52. doi:10.1016/j.annemergmed.2007.02.022.

    Article  PubMed  Google Scholar 

  27. Beltrame JF, Zeitz CJ, Unger SA, Brennan RJ, Hunt A, Moran JL, et al. Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema. Journal of cardiac failure. 1998;4(4):271–9.

    Article  CAS  PubMed  Google Scholar 

  28. Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 1998;351(9100):389–93. doi:10.1016/S0140-6736(97)08417-1.

    Article  CAS  PubMed  Google Scholar 

  29. Alexander P, Alkhawam L, Curry J, Levy P, Pang PS, Storrow AB, et al. Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review. Am J Emerg Med. 2015;33(2):133–41. doi:10.1016/j.ajem.2014.09.009.

    Article  PubMed  PubMed Central  Google Scholar 

  30. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31. doi:10.1097/01.AOG.0000437382.03963.88.

    Article  Google Scholar 

  31. Al Khaja KA, Sequeira RP, Alkhaja AK, Damanhori AH. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens. 2014;32(3):454–63. doi:10.1097/HJH.0000000000000069.

    Article  CAS  PubMed  Google Scholar 

  32. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955–60. doi:10.1136/bmj.327.7421.955.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Olson-Chen C, Seligman NS. Hypertensive emergencies in pregnancy. Crit Care Clin. 2016;32(1):29–41. doi:10.1016/j.ccc.2015.08.006.

    Article  PubMed  Google Scholar 

  34. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65. doi:10.1056/NEJMoa1214609. This study was the largest study ever performed to test blood pressure targets in intracerebral hemorrhage.

    Article  CAS  PubMed  Google Scholar 

  35. Wang X, Arima H, Heeley E, Delcourt C, Huang Y, Wang J, et al. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study. Hypertension. 2015;65(5):1026–32. doi:10.1161/HYPERTENSIONAHA.114.05044. Important secondary analysis from the largest intracerebral hemorrhage study ever published with evidence of efficacy for early and significant blood pressure reduction.

    Article  CAS  PubMed  Google Scholar 

  36. Hemphill 3rd JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60. doi:10.1161/STR.0000000000000069.

    Article  PubMed  Google Scholar 

  37. Morgenstern LB, Hemphill 3rd JC, Anderson C, Becker K, Broderick JP, Connolly Jr ES, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29. doi:10.1161/STR.0b013e3181ec611b.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Miller J, Kinni H, Lewandowski C, Nowak R, Levy P. Management of hypertension in stroke. Ann Emerg Med. 2014;64(3):248–55. doi:10.1016/j.annemergmed.2014.03.004. This review article on the management of hypertension in stroke expands significantly upon the discussion in this article, including analysis of the literature supporting current guidelines for blood pressure control in ischemic and hemorrhagic stroke.

    Article  PubMed  Google Scholar 

  39. Fisher M, Bastan B. Identifying and utilizing the ischemic penumbra. Neurology. 2012;79(13 Suppl 1):S79–85. doi:10.1212/WNL.0b013e3182695814.

    Article  PubMed  Google Scholar 

  40. Strandgaard S, Paulson OB. Regulation of cerebral blood flow in health and disease. J Cardiovasc Pharmacol. 1992;19 Suppl 6:S89–93.

    Article  PubMed  Google Scholar 

  41. Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21(7):804–10. doi:10.1097/00004647-200107000-00005.

    Article  CAS  PubMed  Google Scholar 

  42. Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57(1):18–24.

    Article  CAS  PubMed  Google Scholar 

  43. He J, Zhang Y, Xu T, Zhao Q, Wang D, Chen CS, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA. 2014;311(5):479–89. doi:10.1001/jama.2013.282543.

    Article  CAS  PubMed  Google Scholar 

  44. Sandset EC, Bath PM, Boysen G, Jatuzis D, Korv J, Luders S, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377(9767):741–50. doi:10.1016/S0140-6736(11)60104-9.

    Article  CAS  PubMed  Google Scholar 

  45. Wang H, Tang Y, Rong X, Li H, Pan R, Wang Y, et al. Effects of early blood pressure lowering on early and long-term outcomes after acute stroke: an updated meta-analysis. PloS one. 2014;9(5):e97917. doi:10.1371/journal.pone.0097917.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Connolly Jr ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711–37. doi:10.1161/STR.0b013e3182587839.

    Article  PubMed  Google Scholar 

  47. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308(11):619–24. doi:10.1056/NEJM198303173081103.

    Article  CAS  PubMed  Google Scholar 

  48. Panerai RB. Transcranial Doppler for evaluation of cerebral autoregulation. Clin Auton Res. 2009;19(4):197–211. doi:10.1007/s10286-009-0011-8.

    Article  PubMed  Google Scholar 

  49. Mazzeo AT, Di Pasquale R, Settineri N, Bottari G, Granata F, Farago G, et al. Usefulness and limits of near infrared spectroscopy monitoring during endovascular neuroradiologic procedures. Minerva Anestesiol. 2012;78(1):34–45.

    CAS  PubMed  Google Scholar 

  50. Moerman A, De Hert S. Cerebral oximetry: the standard monitor of the future? Curr Opin Anaesthesiol. 2015;28(6):703–9. doi:10.1097/ACO.0000000000000256.

    Article  CAS  PubMed  Google Scholar 

  51. Schytz HW, Guo S, Jensen LT, Kamar M, Nini A, Gress DR, et al. A new technology for detecting cerebral blood flow: a comparative study of ultrasound tagged NIRS and 133Xe-SPECT. Neurocrit Care. 2012;17(1):139–45. doi:10.1007/s12028-012-9720-2.

    Article  PubMed  Google Scholar 

  52. Kotchen TA, Cowley Jr AW, Liang M. Ushering hypertension into a new era of precision medicine. JAMA. 2016;315(4):343–4. doi:10.1001/jama.2015.18359.

    Article  PubMed  Google Scholar 

  53. Ankolekar S, Fuller M, Cross I, Renton C, Cox P, Sprigg N, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke. 2013;44(11):3120–8. doi:10.1161/STROKEAHA.113.001301.

    Article  CAS  PubMed  Google Scholar 

  54. Wilson SS, Ayaz SI, Levy PD. Relaxin: a novel agent for the treatment of acute heart failure. Pharmacotherapy. 2015;35(3):315–27. doi:10.1002/phar.1548.

    Article  CAS  PubMed  Google Scholar 

  55. Adebayo O, Rogers RL. Hypertensive emergencies in the emergency department. Emerg Med Clin North Am. 2015;33(3):539–51. doi:10.1016/j.emc.2015.04.005.

    Article  PubMed  Google Scholar 

  56. Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68(3):283–97.

    Article  CAS  PubMed  Google Scholar 

  57. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356(9227):411–7. doi:10.1016/S0140-6736(00)02539-3.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph B. Miller.

Ethics declarations

Conflict of Interest

Drs. Kinni and Amer declare no conflicts of interest. Dr. Miller declares personal fees from The Medicines Company. Dr. Levy declares personal fees and non-financial support from The Medicines Company and Chiesi USA.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Hypertension and Emergency Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miller, J.B., Kinni, H., Amer, A. et al. Therapies to Reduce Blood Pressure Acutely. Curr Hypertens Rep 18, 43 (2016). https://doi.org/10.1007/s11906-016-0651-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-016-0651-8

Keywords

Navigation